Frequency Competitors
| KRRO Stock | 11.48 0.31 2.78% |
Frequency Therapeutics vs LB Pharmaceuticals Correlation
Very weak diversification
The correlation between Frequency Therapeutics and LBRX is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Frequency Therapeutics and LBRX in the same portfolio, assuming nothing else is changed.
Moving against Frequency Stock
As of the 17th of February 2026, Return On Tangible Assets is likely to drop to -0.35. In addition to that, Return On Capital Employed is likely to drop to -0.41. At this time, Frequency Therapeutics' Non Current Assets Total are very stable compared to the past year. As of the 17th of February 2026, Non Currrent Assets Other is likely to grow to about 7.5 M, while Total Assets are likely to drop about 173.2 M.Frequency Therapeutics Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Frequency Therapeutics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Frequency and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Frequency Therapeutics does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Frequency Stock performing well and Frequency Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Frequency Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENGN | 3.78 | 0.23 | 0.06 | 0.15 | 4.58 | 8.59 | 22.57 | |||
| ALT | 3.91 | 0.22 | 0.04 | 0.35 | 5.10 | 9.80 | 33.75 | |||
| ANNX | 4.15 | 0.94 | 0.22 | 3.10 | 3.56 | 11.30 | 35.10 | |||
| DBVT | 4.50 | 0.87 | 0.17 | (2.13) | 4.11 | 10.53 | 36.36 | |||
| LRMR | 3.30 | (0.23) | 0.00 | (0.23) | 0.00 | 6.96 | 20.14 | |||
| AMRN | 2.38 | (0.07) | 0.00 | 0.26 | 0.00 | 4.94 | 21.26 | |||
| SLN | 3.24 | (0.27) | 0.00 | 0.29 | 0.00 | 7.72 | 23.80 | |||
| ANRO | 4.05 | 0.67 | 0.11 | 0.80 | 5.43 | 10.64 | 26.04 | |||
| AURA | 2.47 | (0.14) | 0.00 | (0.04) | 0.00 | 5.00 | 18.08 | |||
| LBRX | 3.63 | 0.77 | 0.19 | 1.77 | 3.37 | 8.56 | 23.59 |
Cross Equities Net Income Analysis
Compare Frequency Therapeutics and related stocks such as enGene Holdings Common, Altimmune, and Annexon Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALT | 277.3 K | (3.8 M) | (4.9 M) | (11.7 M) | (10 M) | (3.4 M) | 193.9 M | (46.4 M) | (39.2 M) | (20.5 M) | (49 M) | (97.1 M) | (84.7 M) | (88.4 M) | (95.1 M) | (85.6 M) | (81.3 M) |
| ANNX | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.3 M) | (37.2 M) | (62.7 M) | (127.8 M) | (138.3 M) | (134.2 M) | (138.2 M) | (124.4 M) | (130.6 M) |
| DBVT | (6.1 M) | (9.4 M) | (17 M) | (26.6 M) | (29.1 M) | (48.5 M) | (126.3 M) | (177.2 M) | (190.3 M) | (172 M) | (159.6 M) | (97.8 M) | (96.3 M) | (72.7 M) | (113.7 M) | (102.3 M) | (107.5 M) |
| LRMR | (13.2 M) | (13.2 M) | (13.9 M) | (14 M) | (36.6 M) | (74.3 M) | (57.9 M) | (52 M) | (61.4 M) | (23.1 M) | (42.3 M) | (50.3 M) | (34.2 M) | (36.9 M) | (80.6 M) | (72.5 M) | (68.9 M) |
| ANRO | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (9.2 M) | (27.7 M) | (36.3 M) | (61.4 M) | (61.4 M) | (55.3 M) | (52.5 M) |
| AURA | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (22.2 M) | (35.3 M) | (58.8 M) | (76.4 M) | (86.9 M) | (78.2 M) | (82.1 M) |
Frequency Therapeutics and related stocks such as enGene Holdings Common, Altimmune, and Annexon Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Frequency Therapeutics financial statement analysis. It represents the amount of money remaining after all of Frequency Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Frequency Therapeutics Competitive Analysis
The better you understand Frequency Therapeutics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Frequency Therapeutics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Frequency Therapeutics' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Frequency Therapeutics Competition Performance Charts
Five steps to successful analysis of Frequency Therapeutics Competition
Frequency Therapeutics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Frequency Therapeutics in relation to its competition. Frequency Therapeutics' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Frequency Therapeutics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Frequency Therapeutics' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Frequency Therapeutics, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Frequency Therapeutics position
In addition to having Frequency Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Silver Thematic Idea Now
Silver
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Frequency Therapeutics Correlation with its peers. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Biotechnology sector continue expanding? Could Frequency diversify its offerings? Factors like these will boost the valuation of Frequency Therapeutics. Expected growth trajectory for Frequency significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Frequency Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Frequency Therapeutics requires distinguishing between market price and book value, where the latter reflects Frequency's accounting equity. The concept of intrinsic value - what Frequency Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Frequency Therapeutics' price substantially above or below its fundamental value.
Understanding that Frequency Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Frequency Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Frequency Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.